CPH Group AG has successfully completed the acquisition of LOG Pharma with sites in Israel and Hungary. The acquisition strengthens the company's global market position in the pharmaceutical packaging sector.
CPH Group AG announced that the acquisition of LOG Pharma, which was announced on 4 December 2024, has been successfully completed. LOG Pharma will be integrated into the Packaging Division of Perlen Packaging, but will retain its existing brand name.
Strengthening the global market position
The acquisition expands the CPH Group's presence in Israel and Hungary and strengthens its position in growth regions in the pharmaceutical packaging sector. With this acquisition, Perlen Packaging is adding vials and containers as complementary primary pharmaceutical packaging to its product portfolio.
„With the acquisition of LOG Pharma, we are continuing our global expansion strategy in a targeted manner and strengthening our market presence in high-growth regions,“ explains Dr Peter Schildknecht, CEO of the CPH Group.
Future prospects and integration
The CPH Group now operates at 14 locations worldwide. The acquisition of LOG Pharma is a further step in the realisation of the company's strategic focus on high-potential growth markets.
„This acquisition enables us to further expand our product range for the pharmaceutical industry and offer our customers an even broader range of packaging solutions,“ adds Gerold Brütsch, CFO of the CPH Group.
According to the CPH Group, the successful integration of LOG Pharma strengthens its commitment to the pharmaceutical packaging sector. The expanded capacities and product solutions will help the company to further establish itself as a leading provider in this market segment, the company concludes.
Source: CPH Group AG
